CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-27 | Pande Vijay Satyanand Director | Conversion · Series D Preferred Stock | −2,924,318 | 0 | ||
| 2024-09-27 | ENRIGHT PATRICK G Director | Conversion | +1,310,589 | 1,310,589 | ||
| 2024-09-27 | ENRIGHT PATRICK G Director | Purchase | +400,000 | $18.00 | $7.2M | 1,710,589 |
| 2024-09-27 | ENRIGHT PATRICK G Director | Conversion · Series D Preferred Stock | −5,848,637 | 0 | ||
| 2024-09-27 | HEALY JAMES Director | Conversion | +1,638,236 | 1,638,236 | ||
| 2024-09-27 | HEALY JAMES Director | Purchase | +588,888 | $18.00 | $10.6M | 2,227,124 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +11,113 | $18.00 | $200K | 11,113 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +18,353 | $18.00 | $330K | 18,353 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +21,814 | $18.00 | $393K | 21,814 |
| 2024-09-27 | HEALY JAMES Director | Purchase | +26,497 | $18.00 | $477K | 26,497 |
| 2024-09-27 | HEALY JAMES Director | Conversion · Series D Preferred Stock | −7,310,796 | 0 | ||
| 2024-09-25 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-09-25 | Fortney Kristen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +424,827 | 424,827 | ||
| 2024-09-25 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-09-25 | Hemrajani Rekha Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-09-25 | Davidson Michael H. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-09-25 | GARNIER JEAN PIERRE Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2024-09-25 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +4,952 | 4,952 | ||
| 2024-08-19 | GARNIER JEAN PIERRE Director | Grant or award · Stock Option (Right to Buy) | +141,609 | 141,609 | ||
| 2024-04-17 | Fortney Kristen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +708,044 | 708,044 |
Page 6 of 7 · 124 trades